AEVOE CORP. v. AE Tech Co., Ltd.
Filing
512
ORDER Granting in part and Denying in part 240 Plaintiff's Motion to Dismiss 231 and 232 Amended Counterclaims and Denying 242 Plaintiff's Motion to Strike Defendants' Affirmative Defense of Inequitable Conduct. Defendants' Counterclaim for False Marking is DISMISSED with prejudice. Signed by Chief Judge Gloria M. Navarro on 02/25/2014. (Copies have been distributed pursuant to the NEF - AC)
1
UNITED STATES DISTRICT COURT
2
DISTRICT OF NEVADA
3
AEVOE CORP., a California corporation,
4
5
6
7
8
9
10
)
)
Plaintiff,
)
vs.
)
)
AE TECH CO., LTD., a Taiwan corporation; )
S&F Corporation dba SF PLANET
)
CORPORATION, a Minnesota corporation, )
and GREATSHIELD INC., a Minnesota
)
corporation,
)
Defendants.
)
)
Case No.: 2:12-cv-00053-GMN-NJK
ORDER
Pending before the Court is the Motion to Dismiss Defendants’ Counterclaims (ECF No.
11
12
240) and Motion to Strike Defenses (ECF No. 242) filed by Plaintiff Aevoe Corporation
13
(“Plaintiff”). Defendants AE Tech Co., LTD, SF Planet Corporation, and Greatshield Inc.
14
(collectively, “Defendants”) filed a Response (ECF Nos. 262, 263) and Plaintiff filed a Reply
15
(ECF No. 276).
16
I.
17
BACKGROUND
This case arises from Defendants’ alleged infringement of United States Patent No.
18
8,044,942 (“the ’942 Patent”). (Am. Compl. ¶¶ 35-44 , ECF No. 44.) Specifically, the ’942
19
Patent relates to touch screen protection products. (Id. ¶ 36, ECF No. 44.) See generally United
20
States Patent No. 8,044,942 (filed June 14, 2011) (issued Oct. 25, 2011).
21
Plaintiff initiated this action on January 11, 2012. (Compl., ECF No. 1.) Plaintiff
22
subsequently filed its Amended Complaint on March 14, 2012. (Am. Compl., ECF No.44.)
23
Defendant AE Tech filed its Answer on March 30, 2012 (Answer, ECF No. 51) and Defendants
24
S&F Corporation and Greatshield Inc. filed their Answer on April 9, 2012 (Answer, ECF No.
25
Page 1 of 13
1
52).1 In the Answers, Defendants assert multiple affirmative defenses: (1) unclean hands; (2)
2
unenforceability; (3) noninfringement; (4) invalidity; (5) inequitable conduct; and (6) any
3
additional affirmative defenses that become apparent during the course of the litigation.
4
(Answer at 5:26-6:13, ECF No. 51.) Defendants also assert four counterclaims: (1) declaratory
5
judgment of noninfringement; (2) declaratory judgment of invalidity; (3) declaratory judgment
6
of unenforceability; and (4) false marking. (Id. ¶¶ 25-51.)
7
In response to Defendants’ Answers, Plaintiff filed a motion in which Plaintiff requested
8
that the Court strike Defendants’ Inequitable Conduct Affirmative Defense and that the Court
9
dismiss Defendants’ Unenforceability and False Marking Counterclaims. (See generally Mot.
10
to Dismiss, ECF No. 67.) The Court granted Plaintiff’s motion, but granted Defendants leave
11
to file an amended answer and counterclaims. (Order, ECF No. 217.) Thereafter, Defendant
12
AE Tech filed an Amended Answer (ECF No. 231) and Defendants S&F Corporation and
13
Greatshield Inc. filed a joint Amended Answer (ECF No. 232). Plaintiff subsequently filed a
14
second motion seeking dismissal of Defendants’ Unenforceability and False Marking
15
Counterclaims and requesting that the Court strike Defendants’ inequitable conduct affirmative
16
defense. (ECF Nos. 240, 242.)
17
II.
18
19
20
21
22
CHOICE OF LAW
“On procedural issues, [courts] follow[] the rule of the regional circuit, unless the issue
is unique to patent law and therefore exclusively assigned to the Federal Circuit.” Madey v.
Duke Univ., 307 F.3d 1351, 1358 (Fed. Cir. 2002). If “the issue pertains to or is unique to
patent law,” district courts apply the law of the Federal Circuit “to both substantive and
procedural issues [that are] intimately involved in the substance of enforcement of the patent
23
24
1
25
Both Answers are substantially similar. In fact, the Answers appear identical in the sections referring to the
affirmative defenses and the asserted counterclaims. (Compare Answer ¶¶ 46-51, ECF No. 51 with Answer ¶¶
46-51, ECF No. 52.) Accordingly, this Order refers only to the Answer filed by AE Tech. (Answer, ECF No.
51.)
Page 2 of 13
1
right.” Flex-Foot, Inc. v. CRP, Inc., 238 F.3d 1362, 1365 (Fed. Cir. 2001) (internal quotation
2
marks and citations omitted). Furthermore, the question of which circuit’s law to apply is
3
decided on an issue-by-issue basis. Id.
4
III.
5
6
7
8
9
10
11
12
PLAINTIFF’S MOTION TO DISMISS
Plaintiff requests that this Court dismiss Defendants’ Counterclaim for Declaratory
Judgment of Unenforceability and Defendants’ Counterclaim for False Marking. (Mot. to
Dismiss 1:11–15, ECF No. 240.) For the reasons stated below, Plaintiff’s Motion to Dismiss is
granted-in-part and denied-in-part.
A.
Legal Standard
“A motion to dismiss for failure to state a claim upon which relief can be granted is a
purely procedural question not pertaining to patent law.” McZeal v. Sprint Nextel Corp., 501
F.3d 1354, 1355-56 (Fed. Cir. 2007). Accordingly, this Court applies the law of the regional
13
circuit, the Ninth Circuit, when analyzing whether a Complaint alleging patent infringement
14
states a valid claim. Id. at 1356.
15
When considering a motion to dismiss under Rule 12(b)(6) for failure to state a claim,
16
dismissal is appropriate only when the complaint does not give the defendant fair notice of a
17
legally cognizable claim and the grounds on which it rests. See Bell Atl. Corp. v. Twombly, 550
18
U.S. 544, 555 (2007). In considering whether the complaint is sufficient to state a claim, the
19
Court will take all material allegations as true and construe them in the light most favorable to
20
the plaintiff. See NL Indus., Inc. v. Kaplan, 792 F.2d 896, 898 (9th Cir. 1986).
21
The Court, however, is not required to accept as true allegations that are merely
22
conclusory, unwarranted deductions of fact, or unreasonable inferences. See Sprewell v. Golden
23
State Warriors, 266 F.3d 979, 988 (9th Cir. 2001). A formulaic recitation of a cause of action
24
with conclusory allegations is not sufficient; a plaintiff must plead facts showing that a
25
violation is plausible, not just possible. Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (citing
Twombly, 550 U.S. at 555) (emphasis added).
Page 3 of 13
1
If the court grants a motion to dismiss, it must then decide whether to grant leave to
2
amend. The court should “freely give” leave to amend when there is no “undue delay, bad
3
faith[,] dilatory motive on the part of the movant . . . undue prejudice to the opposing party by
4
virtue of . . . the amendment, [or] futility of the amendment . . . .” Fed. R. Civ. P. 15(a); Foman
5
v. Davis, 371 U.S. 178, 182 (1962). Generally, leave to amend is only denied when it is clear
6
that the deficiencies of the complaint cannot be cured by amendment. See DeSoto v. Yellow
7
Freight Sys., Inc., 957 F.2d 655, 658 (9th Cir. 1992).
8
B.
Plaintiff’s Motion to Dismiss Defendants’ False Marking Counterclaim
9
Defendants’ final counterclaim alleges that Plaintiff has engaged in false marking as
10
prohibited by 35 U.S.C. § 292. (AE Tech Am. Answer 29:¶155–31:¶172, ECF No. 231; S&F &
11
Greatshield Am. Answer 29:¶148–32:¶165, ECF No. 232.)2 Whether the party alleging false
12
marking has satisfied the heightened pleading standard of Rule 9(b) is governed by Federal
13
Circuit law because “it bears on an issue that ‘pertains to or is unique to patent law.’” See
14
Central Admixture Pharmacy Servs., Inc. v. Advanced Cardiac Solutions, P.C., 482 F.3d 1347,
15
1356 (Fed. Cir. 2007).
Section 292(a) prohibits an entity from, among other things, “affix[ing] to . . . any
16
17
unpatented article, the word ‘patent’ or any word or number importing that the same is
18
patented, for the purpose of deceiving the public . . . .” 35 U.S.C. § 292(a). The statute further
19
provides, in § 292(b), that any “person who has suffered a competitive injury as a result of a
20
violation of this section may file a civil action in a district court of the United States for
21
recovery of damages adequate to compensate for the injury.” 35 U.S.C. § 292(b). Thus, the
22
statute first requires that the patent indicia be affixed to an unpatented article. 35 U.S.C.
23
§ 292(a). Second, the statute requires Defendants to allege that the false marking was done “for
24
25
2
Because these sections of the two Answers contain the same factual allegations, the Court will refer only to the
Answer filed by Defendant AE Tech. (Compare AE Tech Am. Answer 29:¶155–31:¶172, ECF No. 231 with
S&F & Greatshield Am. Answer 29:¶148–32:¶165, ECF No. 232.)
Page 4 of 13
1
the purpose of deceiving the public.” 35 U.S.C. § 292(a). Finally, the statute requires
2
Defendants to allege sufficient facts to plausibly establish that, as a result of Plaintiff’s alleged
3
mismarking of the laptop screen protector products, Defendants’ ability to compete against
4
Plaintiff in the market for screen protector products was impaired, resulting in tangible
5
economic loss to Defendants. 35 U.S.C. § 292(b); see e.g, Fisher-Price, Inc. v. Kids II, Inc.,
6
No. 10-CV-00988A F, 2011 WL 6409665, at *9 (W.D.N.Y. Dec. 21, 2011).
7
Finally, because false marking “sounds in fraud,” to survive a motion to dismiss, the
8
party alleging false marking must satisfy the heightened pleading standard of Rule 9(b) of the
9
Federal Rules of Civil Procedure. Juniper Networks, Inc. v. Shipley, 643 F.3d 1346, 1350 (Fed.
10
Cir. 2011). As such, a complaint that alleges false marking “is insufficient when it only asserts
11
conclusory allegations.” In re BP Lubricants USA Inc., 637 F.3d 1307, 1309 (Fed. Cir. 2011).
12
Rule 9(b) requires that “[i]n alleging fraud or mistake, a party must state with particularity the
13
circumstances constituting fraud or mistake.” Fed. R. Civ. P. 9(b). Therefore, a pleading that
14
simply recites the substantive elements of the false marking statute without setting forth the
15
particularized factual bases for the allegation, cannot satisfy Rule 9(b).
16
17
1.
Patent Indicia Affixed to an Unpatented Article
Defendants assert that Plaintiff “marked the packaging of the iVisor Pro for MacBook
18
with the notice ‘Patented technology ensures that the iVisor Pro is 100% bubble-free upon
19
installation’ . . . .” (Am. Answer 29:¶157, ECF No. 231.) Defendants further assert that “there
20
is no United States patent that covers the iVisor Pro for MacBook or any method used to
21
manufacture this product.” (Am. Answer 31:¶168.) Similarly, Defendants assert that Plaintiff
22
“marked webpages advertising or offering to sell Aevoe’s iVisor XT for iPad indicating that
23
Aevoe’s iVisor XT for iPad was patented prior to issuance of the ’942 patent.” (Am. Answer
24
30:¶159.) Accordingly, the Court finds that Defendants have adequately pleaded the first
25
element of their false marking counterclaim.
Page 5 of 13
1
2.
Intent to Deceive the Public
2
To survive Plaintiff’s Motion to Dismiss, Defendants’ Counterclaim for False Marking
3
must contain “some objective indication to reasonably infer” that Plaintiff intended to deceive
4
the public. In re BP Lubricants USA Inc., 637 F.3d 1307, 1311 (Fed. Cir. 2011). “[T]he fact of
5
misrepresentation coupled with proof that the party making it had knowledge of its falsity is
6
enough to warrant drawing the inference that there was a fraudulent intent.” Id. (quotation
7
marks omitted).
8
9
In Defendants’ Counterclaim, they appear to allege false marking of two products. First,
Defendants’ allege that Plaintiff marked its “iVisor AG for MacBook” as patented when no
10
such patent has ever issued. (Am. Answer 29:¶¶157–58, 31:¶168.) Similarly, Defendants
11
allege that Plaintiff marked its “iVisor XT for iPad” as patented before the ’942 Patent issued.
12
(Id. 30:¶159.) In addition, Defendants assert that Plaintiff “received notice in a letter from an
13
attorney, informing Aevoe that it was falsely marking its products as patented.” (Id. 30:¶165.)
14
However, this letter related only to Plaintiff’s marking of the iVisor XT for iPad. (Id. 30:¶166.)
15
Defendants have failed to allege any additional facts related to Plaintiff’s intent to deceive or
16
knowledge of the falsity of the patent marking on Plaintiff’s iVisor AG for MacBook product.
17
For these reasons, the Court concludes that Defendants’ Counterclaim for False Marking
18
adequately alleges Plaintiff’s deceptive intent as it relates to the iVisor XT for iPad, but has not
19
alleged the requisite deceptive intent as it relates to the iVisor AG for MacBook Pro.
20
21
3.
Competitive Injury
Defendants dedicate several paragraphs in their Counterclaim for False Marking to the
22
element of competitive injury. (See Am. Answer 30:¶¶160–64, 31:¶¶169–70, ECF No. 231.)
23
As noted above, Defendants appear to assert that Plaintiff violated the false marking statute on
24
two of its products: the iVisor Pro for MacBook and the iVisor XT for iPad. However,
25
Defendants have not provided any factual allegations from which the Court can infer that
Page 6 of 13
1
Plaintiff’s alleged false marking of the iVisor XT for iPad caused a competitive injury to
2
Defendants. Rather, the allegations related to competitive injury target only the iVisor Pro for
3
MacBook. For example, Defendants allege that their “decision not to sell a screen protector for
4
the Apple MacBook laptop computer after it found out that Aevoe had marked the packaging of
5
its iVisor Pro for Macbook” as patented. (Id. 30:¶161; see also id. 30:¶162–64, 31:169–70.)
6
The Court recognizes that these allegations may be sufficient to establish the competitive injury
7
element of Defendants’ false marking counterclaim as it relates to the iVisor Pro for MacBook.
8
However, as discussed above in Section III.B.2, Defendants failed to adequately plead that
9
Plaintiff intended to deceive the public as it relates to the alleged false marking of the iVisor
10
Pro for MacBook. Noticeably absent from Defendants’ Counterclaim is any assertion that they
11
suffered competitive injury as a result of Plaintiff’s alleged false marking of the iVisor XT for
12
iPad.
13
For these reasons, the Court GRANTS Plaintiff’s Motion to Dismiss the Counterclaim
14
for False Marking that appears in Defendant AE Tech’s Amended Answer (ECF No. 231) and
15
the Counterclaim for False Marking that appears in the Amended Answer filed by Defendants
16
S&F Corporation and Greatshield (ECF No. 232). Because Defendants have failed to cure the
17
deficiencies that the Court previously identified (see Order, ECF No. 217), the Court finds that
18
amendment would be futile and declines to grant Defendants leave to file another amended
19
answer.
20
C.
21
Inequitable conduct occurs when the patent applicant fails to disclose material
Plaintiff’s Motion to Dismiss Defendants’ Inequitable Conduct Counterclaim
22
information, or submits false material information, with an intent to deceive the patent
23
examiner. Kingsdown Med. Consultants, Ltd. v. Hollister Inc., 863 F.2d 867, 872 (Fed. Cir.
24
1988); see also 37 C.F.R. § 1.56 (“Each individual associated with the filing and prosecution of
25
a patent application has a duty of candor and good faith in dealing with the [Patent] Office,
Page 7 of 13
1
which includes a duty to disclose to the Office all information known to that individual to be
2
material to patentability as defined in this section.”). Inequitable conduct is an equitable
3
defense to patent infringement that, if proved, bars enforcement of a patent. Therasense, Inc. v.
4
Becton, Dickinson & Co., 649 F.3d 1276, 1287 (Fed. Cir. 2011) (en banc).
5
Because inequitable conduct also sounds in fraud, to survive a motion to dismiss, the
6
accused infringer must satisfy the heightened pleading standard of Rule 9(b) of the Federal
7
Rules of Civil Procedure. Exergen Corp. v. Wal-Mart Stores, Inc., 575 F.3d 1312, 1326-27
8
(Fed. Cir. 2009). As discussed above in Section Error! Reference source not found..Error!
9
Reference source not found., Rule 9(b) requires that “[i]n alleging fraud or mistake, a party
10
must state with particularity the circumstances constituting fraud or mistake.” Fed. R. Civ. P.
11
9(b). Thus, “[a] pleading that simply avers the substantive elements of inequitable conduct,
12
without setting forth the particularized factual bases for the allegation, does not satisfy Rule
13
9(b).” Exergen, 575 F.3d at 1326-27.
14
To plead inequitable conduct, the accused infringer must allege that (1) “the applicant
15
misrepresented or omitted material information” (2) “with the specific intent to deceive the
16
PTO.” Therasense, 649 F.3d at 1287. To satisfy the heightened pleading requirement of Rule
17
9(b), the accused infringer must identify “the specific who, what, when, where, and how of the
18
material misrepresentation or omission committed before the PTO.” Exergen, 575 F.3d at 1327.
19
Specifically, “[a] charge of inequitable conduct based on a failure to disclose will survive a
20
motion to dismiss only if the plaintiff’s complaint recites facts from which the court may
21
reasonably infer that a specific individual both knew of invalidating information that was
22
withheld from the PTO and withheld that information with a specific intent to deceive the
23
PTO.” Delano Farms Co. v. Cal. Table Grape Comm’n, 655 F.3d 1337, 1350 (Fed. Cir. 2011)
24
(emphasis added).
25
Page 8 of 13
1
Whether the accused infringer has satisfied the heightened pleading standard of Rule
2
9(b) in pleading inequitable conduct is governed by Federal Circuit law because “it bears on an
3
issue that ‘pertains to or is unique to patent law.’” Central Admixture Pharmacy Servs., Inc. v.
4
Advanced Cardiac Solutions, P.C., 482 F.3d 1347, 1356 (Fed. Cir. 2007).
5
1.
Who, What, Where, Why, and How of the Alleged Failure to Disclose
6
Material Prior Art
7
a.
8
9
The “Who”
In Exergen, the Federal Circuit instructed that the pleading must “name the specific
individual associated with the filing or prosecution of the application . . . , who both knew of
10
the material information and deliberately withheld or misrepresented it.” Exergen, 575 F.3d at
11
1329 (holding that a general reference to “Exergen, its agents and/or attorneys” was insufficient
12
to satisfy this requirement); see also Avid Identification Sys., Inc. v. Crystal Import Corp., 603
13
F.3d 967, 974 n.1 (Fed. Cir. 2010) (noting that the duty of candor imposed by 37 C.F.R. § 1.56
14
applies only to “individuals”). Similarly, in Oracle Corp. v. DrugLogic, Inc., the district court
15
found that a recitation of “[e]ach attorney or agent who prepared or prosecuted the application”
16
was insufficient to satisfy this pleading requirement. 807 F. Supp. 2d 885, 898 (N.D. Cal.
17
2011).
18
In their Amended Answers, Defendants identify four specific individuals that allegedly
19
withheld material information from the USPTO: (1) Michael Leonhard; (2) Jonathan Lin; (3)
20
Steven Huang, and (4) Allan Fanucci. (Am. Answer 24:¶128, ECF No. 231.) Accordingly,
21
Defendants’ Counterclaim for Declaratory Judgment of Inequitable Conduct adequately alleges
22
“who” committed the material omissions and/or misrepresentations.
23
b.
The “What”
24
Defendants allege that the specifically identified individuals failed to disclose the
25
existence of Plaintiff’s iVisor AG for MacBook product and Plaintiff’s iVisor Pro for MacBook
Page 9 of 13
1
product. (Am. Answer 24:¶130–25:¶136.) Accordingly, Defendants have adequately alleged
2
“what” the potentially material information was that these individuals withheld from the
3
examiner.
4
5
c.
The “Where”
Under Exergen, Defendants must also allege “which claims, and which limitations in
6
those claims, the withheld references are relevant to, and where in those references the material
7
information is found.” 575 F.3d at 1329.
8
9
Defendants’ Amended Answer satisfies this requirement by alleging that “the examiner
would have rejected at least claim 1” under 35 U.S.C. § 102, in light of the iVisor AG for
10
MacBook reference. (Am. Answer 26:¶144; see also Am. Answer 26:¶145–27:¶:146.)
11
Similarly, Defendants assert that “the examiner would have rejected claims 1-15 of the ’942
12
patent under 35 U.S.C. § 103,” in light of the iVisor Pro for MacBook reference. (Am. Answer
13
27:¶147.) Finally, Defendants assert that “there are no significant differences between the
14
iVisor Pro for MacBook and an iVisor screen protector for an Apple iPhone or iPad embodying
15
the ’942 patent other than the outside dimensions of the screen protectors. (Am. Answer
16
24:¶129.)
17
The Court readily acknowledges that these allegations could be much more clear.
18
However, Defendants’ allegations essentially allege that every limitation of every claim of the
19
’942 Patent is either anticipated, subject to the statutory bar of § 102(b), or rendered obvious
20
because of these laptop screen protector products. Therefore, the Court concludes that
21
Defendants have adequately alleged this requirement.
22
23
d.
The “Why” and “How”
Exergen teaches that to adequately allege inequitable conduct, Defendants must
24
“identify the particular claim limitations, or combination of claim limitations, that are
25
supposedly absent from the information in the record.” 575 F.3d at 1329. Exergen further
Page 10 of 13
1
explains that “[s]uch allegations are necessary to explain both ‘why’ the withheld information
2
is material and not cumulative, and ‘how’ an examiner would have used this information in
3
assessing the patentability of the claims.” Id. at 1329–30.
4
Here, Defendants first allege that the information is not cumulative of the prior art
5
submitted with the application that issued as the ’942 Patent. (See Am. Answer 15:¶¶64–65.)
6
Defendants further explain why these two products are material by stating that “there are no
7
significant differences between the iVisor Pro for MacBook and an iVisor screen protector for
8
an Apple iPhone or iPad embodying the ’942 patent other than the outside dimensions of the
9
screen protectors.” (Am. Answer ¶ 129; see also id. 18:¶86–19:¶91 (explaining the features of
10
the iVisor Pro for MacBook).) In addition, the allegations in Defendants’ Amended Answer,
11
when taken as true, demonstrate that Plaintiff knew that applying the iVisor AG for MacBook
12
to the touch screen portion of a touch screen device would still permit the operation of “at least
13
one function of a touch screen of a touch screen device . . . through the iVisor AG for MacBook
14
screen protector . . . .” (Am. Answer 16:¶68.) Finally, Defendants dedicate several paragraphs
15
to explaining the statutory basis on which the examiner would have rejected the patent claims if
16
the examiner knew about Plaintiff’s laptop screen protector products. (Am. Answer ¶¶ 26:144–
17
27:147.) Accordingly, the Court concludes that the allegations in Defendants’ Amended
18
Answer adequately allege the “why” and the “how” requirements.
19
20
2.
Specific Intent to Deceive
Accused infringers must also plead with particularity facts from which a court may
21
reasonably infer that a specific individual knew of this material information and deliberately
22
withheld it with the specific intent to deceive the PTO. Exergen, 575 F.3d at 1328. “A
23
reasonable inference is one that is plausible and that flows logically from the facts alleged,
24
including any objective indications of candor and good faith. See Therasense, 649 F.3d at 1287.
25
Furthermore, courts should exercise caution when drawing such an inference when that
Page 11 of 13
1
inference arises “solely from the fact that the information was not disclosed; there must be a
2
factual basis for a finding of deceptive intent.” Harrah’s Entm’t, Inc. v. Station Casinos, Inc.,
3
321 F. Supp. 2d 1184, 1189 (D. Nev. 2004) (citing Upjohn Co. v. Mova Pharm. Co., 225 F.3d
4
1306, 1312 (Fed. Cir. 2000)).
5
As before, neither party disputes that the individuals identified in Defendants’ Amended
6
Answer had knowledge of these laptop screen protector products. Therefore, the Court need
7
only address whether Defendants have failed to plead specific intent to deceive with the
8
particularity required by Rule 9(b). In Defendants’ Amended Answer, they allege that “either
9
Michael Leonhard or Jonathan Lin provided Allan Fanucci with a copy of the iVisor AG for
10
MacBook prior to the filling [sic] date or during the pendency of the ’404 application, which
11
led to the ’942 patent.” (Am. Answer 23:¶122.) Defendants further assert that Allan Fanucci
12
had “a copy of a picture of the iVisor AG for MacBook with the letters ‘P.A.’ written on it and
13
circled.” (Am. Answer 23:¶123.) Defendants also contend that “Allan Fanucci understood the
14
iVisor AG for MacBook to be prior art to the ’404 application at the time the ’404 application
15
was pending before the USPTO.” (Am. Answer 24:¶126.) These allegations, when taken as
16
true, are sufficient to provide the Court with a basis to reasonably infer that these individuals
17
acted with the specific intent to deceive the patent examiner.
18
For these reasons, the Court DENIES Plaintiff’s Motion to Dismiss Defendants’
19
Counterclaim for Declaratory Judgment of Unenforceability.
20
IV.
21
PLAINTIFF’S MOTION TO STRIKE
A grant or denial of a motion to strike is not an issue unique to patent law. Therefore,
22
courts apply the law of the regional circuit where appeals from the district court would
23
normally lie. Anchor Wall Sys., Inc. v. Rockwood Retaining Walls, Inc., 340 F.3d 1298, 1313
24
(Fed. Cir. 2003).
25
Page 12 of 13
1
“[T]he function of a 12(f) motion to strike is to avoid the expenditure of time and
2
money that must arise from litigating spurious issues by dispensing with those issues prior to
3
trial . . ..” Sidney-Vinstein v. A.H. Robins Co., 697 F.2d 880, 885 (9th Cir. 1983). Rule 12(f) of
4
the Federal Rules of Civil Procedure provides that a “court may strike from a pleading an
5
insufficient defense or any redundant, immaterial, impertinent, or scandalous matter.” Fed. R.
6
Civ. P. 12(f). In this case, Plaintiff asserts that the Court should strike Defendants’ fifth
7
affirmative defense because it is an insufficient defense. A defense is insufficiently pleaded if
8
it fails to give the plaintiff fair notice of the nature of the defense. See Wyshak v. City Nat'l
9
Bank, 607 F.2d 824, 827 (9th Cir.1979).
10
As discussed in Section III.C, the allegations in Defendants’ Unenforceability
11
Counterclaim are sufficient to survive Plaintiff’s Motion to Dismiss. Thus, Plaintiff’s Motion
12
to Strike Defendants’ Fifth Affirmative Defense is DENIED.
13
V.
CONCLUSION
14
IT IS HEREBY ORDERED that Plaintiff’s Motion to Dismiss (ECF No. 240) is
15
GRANTED-IN-PART and DENIED-IN-PART. The Court DENIES Plaintiff’s Motion as it
16
relates to Defendants’ Counterclaim for Unenforceability. The Court GRANTS Plaintiff’s
17
Motion as it relates to Defendants’ Counterclaim for False Marking. Defendants’ Counterclaim
18
for False Marking is dismissed with prejudice.
19
20
21
IT IS FURTHER ORDERED that Plaintiff’s Motion to Strike Defendants’ Affirmative
Defense of Inequitable Conduct is DENIED.
25
DATED this _____ day of February, 2014.
22
23
24
25
___________________________________
Gloria M. Navarro, Chief Judge
United States District Judge
Page 13 of 13
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?